D64.81Billable
Anemia due to antineoplastic chemotherapy
Chapter 2: Neoplasms
Inclusion Terms
1 item
Inclusion Terms
- •Antineoplastic chemotherapy induced anemia
Billable Code
D64.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Referenced in Diagnoses
Conditions that use this ICD-10 code in their documentation
View documentation for adverse effect of chemotherapy
adverse effect of chemotherapy
View TemplatesAdverse Effect of Antineoplastic Chemotherapy
View documentation for anemia due to chemotherapy
anemia due to chemotherapy
View TemplatesAnemia due to antineoplastic chemotherapy
View documentation for anemia in neoplastic disease
anemia in neoplastic disease
View TemplatesAnemia in Neoplastic Disease
View documentation for anemia requiring transfusion
anemia requiring transfusion
View TemplatesAnemia requiring transfusion
View documentation for chemo induced anemia
chemo induced anemia
View TemplatesChemotherapy-Induced Anemia
View documentation for normochromic normocytic anemia
normochromic normocytic anemia
View TemplatesNormochromic Normocytic Anemia
View documentation for symptomatic anemia
symptomatic anemia
View TemplatesSymptomatic Anemia
Additional Information from Parent Codes
The following information may apply to this code from its parent codes in the ICD-10 hierarchy. This information is important for proper coding and classification.
Parent Codes Referenced:
Notes
8 items
Notes
From C00-D49:
- •Functional activity
- •All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- •Morphology [Histology]
- •Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- •Primary malignant neoplasms overlapping site boundaries
- •A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- •Malignant neoplasm of ectopic tissue
- •Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).